Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexis Moscoso

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Neuroimage|August 11, 2020
Intensity normalization methods in brain FDG-PET quantificationFrancisco J López-González, Jesús Silva-Rodríguez, José Paredes-Pacheco, et al.
EJNMMI Research|February 26, 2025
Hypometabolism and atrophy patterns associated with Niemann-Pick type CJesús Silva-Rodríguez, Cristina Castro, Julia Cortés, et al.
European Radiology|December 23, 2020
Correction to: Is FDG-PET texture analysis related to intratumor biological heterogeneity in lung cancer?Manuel Piñeiro-Fiel, Alexis Moscoso, Lucía Lado-Cacheiro, et al.
Neuroimage|September 28, 2024
Quantitative brain [<sup>18</sup>F]FDG PET beyond normal blood glucose levelsDavid Rey-Bretal, Lara García-Varela, Noemí Gómez-Lado, et al.
Nature Communications|January 3, 2024
Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer's diseaseNicolai Franzmeier, Amir Dehsarvi, Anna Steward, et al.
European Radiology|November 28, 2020
Is FDG-PET texture analysis related to intratumor biological heterogeneity in lung cancer?Manuel Piñeiro-Fiel, Alexis Moscoso, Lucía Lado-Cacheiro, et al.
Alzheimer'S Research & Therapy|November 8, 2022
Combining tau-PET and fMRI meta-analyses for patient-centered prediction of cognitive decline in Alzheimer's diseaseDavina Biel, Ying Luan, Matthias Brendel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 5, 2025
Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's diseaseAntoine Leuzy, Ariane Bollack, Daniela Pellegrino, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 25, 2024
Advancing Tau PET Quantification in Alzheimer Disease with Machine Learning: Introducing THETA, a Novel Tau Summary MeasureRobel K Gebre, Alexis Moscoso Rial, Sheelakumari Raghavan, et al.
Research Square|October 27, 2023
Advancing Tau-PET quantification in Alzheimer's disease with machine learning: introducing THETA, a novel tau summary measureRobel K Gebre, Alexis Moscoso Rial, Sheelakumari Raghavan, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Neuroimage|August 11, 2020
Intensity normalization methods in brain FDG-PET quantificationFrancisco J López-González, Jesús Silva-Rodríguez, José Paredes-Pacheco, et al.
EJNMMI Research|February 26, 2025
Hypometabolism and atrophy patterns associated with Niemann-Pick type CJesús Silva-Rodríguez, Cristina Castro, Julia Cortés, et al.
European Radiology|December 23, 2020
Correction to: Is FDG-PET texture analysis related to intratumor biological heterogeneity in lung cancer?Manuel Piñeiro-Fiel, Alexis Moscoso, Lucía Lado-Cacheiro, et al.
Neuroimage|September 28, 2024
Quantitative brain [<sup>18</sup>F]FDG PET beyond normal blood glucose levelsDavid Rey-Bretal, Lara García-Varela, Noemí Gómez-Lado, et al.
Nature Communications|January 3, 2024
Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer's diseaseNicolai Franzmeier, Amir Dehsarvi, Anna Steward, et al.
European Radiology|November 28, 2020
Is FDG-PET texture analysis related to intratumor biological heterogeneity in lung cancer?Manuel Piñeiro-Fiel, Alexis Moscoso, Lucía Lado-Cacheiro, et al.
Alzheimer'S Research & Therapy|November 8, 2022
Combining tau-PET and fMRI meta-analyses for patient-centered prediction of cognitive decline in Alzheimer's diseaseDavina Biel, Ying Luan, Matthias Brendel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 5, 2025
Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's diseaseAntoine Leuzy, Ariane Bollack, Daniela Pellegrino, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 25, 2024
Advancing Tau PET Quantification in Alzheimer Disease with Machine Learning: Introducing THETA, a Novel Tau Summary MeasureRobel K Gebre, Alexis Moscoso Rial, Sheelakumari Raghavan, et al.
Research Square|October 27, 2023
Advancing Tau-PET quantification in Alzheimer's disease with machine learning: introducing THETA, a novel tau summary measureRobel K Gebre, Alexis Moscoso Rial, Sheelakumari Raghavan, et al.
Pageof 5